highly significantP value < 0.001
After 10 weeks treatment with the trial drug, highly significant improvement was observed in the clinical features of IDA with P value < 0.001.
After 10 weeks treatment with the trial drug, highly significant improvement was observed in the clinical features of IDA with P value < 0.001.